246 related articles for article (PubMed ID: 15571827)
1. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
Gustavsson CG; Agardh CD
Eur Heart J; 2004 Dec; 25(23):2120-4. PubMed ID: 15571827
[TBL] [Abstract][Full Text] [Related]
2. Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.
Elishkevitz K; Fusman R; Koffler M; Shapira I; Zeltser D; Avitzour D; Arber N; Berliner S; Rotstein R
Diabet Med; 2002 Feb; 19(2):152-6. PubMed ID: 11874432
[TBL] [Abstract][Full Text] [Related]
3. Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony.
Berg AH; Sacks DB
J Clin Pathol; 2008 Sep; 61(9):983-7. PubMed ID: 18755722
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
[TBL] [Abstract][Full Text] [Related]
5. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
[TBL] [Abstract][Full Text] [Related]
6. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients.
Suzuki K; Yagi K; Oka R; Saiki Y; Kubota M; Sugihara M; Ito N; Kawashiri MA; Nohara A; Horita H; Takeda Y; Yamagishi M; Kobayashi J
Clin Chem Lab Med; 2009; 47(1):70-4. PubMed ID: 19072031
[TBL] [Abstract][Full Text] [Related]
7. Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.
Doerr R; Hoffmann U; Otter W; Heinemann L; Hunger-Battefeld W; Kulzer B; Klinge A; Lodwig V; Amann-Zalan I; Sturm D; Tschoepe D; Spitzer SG; Stumpf J; Lohmann T; Schnell O
Diabetologia; 2011 Nov; 54(11):2923-30. PubMed ID: 21773683
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
9. Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients.
Shen Y; Pu LJ; Lu L; Zhang Q; Zhang RY; Shen WF
Cardiology; 2012; 123(2):84-90. PubMed ID: 23018602
[TBL] [Abstract][Full Text] [Related]
10. Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus.
Mita T; Watada H; Uchino H; Shimizu T; Hirose T; Tanaka Y; Kawamori R
Endocr J; 2006 Oct; 53(5):693-8. PubMed ID: 16926521
[TBL] [Abstract][Full Text] [Related]
11. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
[TBL] [Abstract][Full Text] [Related]
12. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
Khan HA; Sobki SH; Khan SA
Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and glycemic control in adults with diabetes.
King DE; Mainous AG; Buchanan TA; Pearson WS
Diabetes Care; 2003 May; 26(5):1535-9. PubMed ID: 12716818
[TBL] [Abstract][Full Text] [Related]
14. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
15. The rise and fall of HbA(1c) as a risk marker for diabetes complications.
Kilpatrick ES
Diabetologia; 2012 Aug; 55(8):2089-91. PubMed ID: 22711013
[TBL] [Abstract][Full Text] [Related]
16. Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin.
Miyazaki A; Kohzuma T; Kasayama S; Koga M
Ann Clin Biochem; 2012 Sep; 49(Pt 5):441-4. PubMed ID: 22715294
[TBL] [Abstract][Full Text] [Related]
17. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients.
Pu LJ; Lu L; Shen WF; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Shen J; Fang DH; Lou S
Circ J; 2007 Jul; 71(7):1067-73. PubMed ID: 17587712
[TBL] [Abstract][Full Text] [Related]
18. HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country.
Sharma TK; Parchwani H; Kaushik GG; Shankar V; Dahiya K; Ghalaut VS; Sharma N
Clin Lab; 2011; 57(7-8):517-22. PubMed ID: 21888015
[TBL] [Abstract][Full Text] [Related]
19. Association between glycosylated haemoglobin A(1c) and endothelial function in an adult non-diabetic population.
Lorbeer R; Empen K; Dörr M; Arndt M; Schipf S; Nauck M; Wallaschofski H; Felix SB; Völzke H
Atherosclerosis; 2011 Aug; 217(2):358-63. PubMed ID: 21570686
[TBL] [Abstract][Full Text] [Related]
20. Acute-phase proteins among patients with type 1 diabetes.
Gomes MB; Piccirillo LJ; Nogueira VG; Matos HJ
Diabetes Metab; 2003 Sep; 29(4 Pt 1):405-11. PubMed ID: 14526268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
